Pregnancy News and Research

Latest Pregnancy News and Research

FDA approves Merz Aesthetics' XEOMIN for temporary improvement of glabellar lines

Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved XEOMIN for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.

22 Jul 2011

Viewpoints: Will Gang of Six compromise work?; endorsing birth control recommendations; Minn. budget deal

Not surprisingly, the plan has drawn complaints from the left about cuts to Social Security and Medicare, and from the right about defense cuts and tax increases. But the senators are right about the need to simplify and broaden the tax code and to put entitlements on a sustainable footing without slashing aid to the most vulnerable.

22 Jul 2011

Scientists find distinct links between smoking during pregnancy and long-term harm for the child

Scientists now understand more about why being exposed to nicotine while you were a fetus will increase your risk of developing cardiovascular disease as an adult. "We have found distinct links between cigarette smoking or even using nicotine patches or gum and the long-term harm for the child," says Dr. DaLiao Xiao, a scientist who works at the Loma Linda University School of Medicine in California.

21 Jul 2011

Senate Commission compiles new threshold limit values for dusts

The 2011 MAK and BAT Values List compiled by the Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, a Senate Commission of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), recommends reducing the general threshold limit value for dust for the alveolar fraction in light of recent studies and classifies such dusts as carcinogenic when these thresholds are exceeded.

21 Jul 2011

Women in embattled regions have limited access and means to use contraceptives

Violent conflict disrupts all aspects of society, including the delivery of the most basic reproductive health services: prenatal and maternal care, family planning, prevention of HIV and other sexually transmitted infections, abortions and emergency caesarian care.

21 Jul 2011

Essential criteria for clinical diagnosis of restless legs syndrome

We've all experienced abnormal sensations in our legs at one time or another, but for as many as 10 percent of the US population, restless legs syndrome (RLS) is a daily occurrence. Characterized by throbbing, pulling, tingling, itching, and crawling sensations, RLS is a neurological disorder that produces unpleasant physical sensations in the extremities and an urge to counteract that sensation by movement.

21 Jul 2011

Caffeine reduces women's chances of becoming pregnant

Caffeine reduces muscle activity in the Fallopian tubes that carry eggs from a woman's ovaries to her womb. "Our experiments were conducted in mice, but this finding goes a long way towards explaining why drinking caffeinated drinks can reduce a woman's chance of becoming pregnant," says Sean Ward, professor of physiology and cell biology, at the University of Nevada School of Medicine, who conducted the study.

21 Jul 2011

IOM panel recommends insurance coverage for contraception

The recommendation by the Institute of Medicine advises that contraceptives for women be treated as one of the several preventive services provided free of charge under the new health law.

21 Jul 2011

Roche, Merck sign new non-exclusive agreement for HCV triple combination therapy

Merck, known as MSD outside the United States and Canada, announced today that it has signed a new non-exclusive agreement with Roche, through the companies' respective subsidiaries, for the global promotion, upon appropriate marketing approvals, of VICTRELIS (boceprevir) as part of a triple combination therapy regimen with peginterferon alfa and ribavirin.

21 Jul 2011

Babies of stressed pregnant mums may have lasting effects

According to a new study high levels of stress during pregnancy can cause an unborn child to have lifelong mental scars. Researchers have found that a mother facing unnecessary crises can leave an imprint in the brains of her children, making them less able to cope as they get older.

20 Jul 2011

Male infertility cause found in defective gene

Researchers have found a new cause of infertility that could allow millions of infertile couples around the world to have a child. The team found a common gene mutation that causes sperm to be far less able to swim through the mucus of the cervix and reach the egg.

20 Jul 2011

Australia sees early rise in flu cases

Australia is gripped with a fourfold increase in the number of people suffering flu. This rise is even before the usual peak season in August and September. Already nearly 8,000 cases have been reported compared with about 2,000 at the same time last year. The increase has disproportionately affected Queensland, NSW and South Australia. In January and February more than 1,700 people were recorded with flu, compared with fewer than 300 the year before.

20 Jul 2011

VIVUS to present topiramate exposure, birth defect data at IEC

VIVUS, Inc. today announced that on August 31, 2011, during the late breaking poster session at the 29th International Epilepsy Congress in Rome, Italy, Dr. Alison Pack, Associate Professor of Clinical Neurology, Department of Neurology, Columbia University Medical Center, will present the results of a retrospective study of medical claims data on oral clefts (OC) and major congenital malformations (MCMs) associated with in utero topiramate exposure.

20 Jul 2011

'Be a Hero for Babies Day' raises $2.75 million for March of Dimes

In communities across the country, Farmers Insurance Group and its agents organized local telethons, golf outings, poker tournaments, gourmet dinners, carnivals and even a Zumba-thon and raised $2.75 million in a one-day fundraiser called Be a Hero for Babies Day benefiting March of Dimes programs to give every baby a healthy start in life.

20 Jul 2011

Janssen presents EDURANT 96-week Phase 3 trial data at International AIDS Society Conference

Janssen Therapeutics, Division of Janssen Products, LP, presented today 96-week findings from two pivotal Phase 3 clinical trials, known as ECHO and THRIVE, comparing the efficacy, safety and virology profile of its non-nucleoside reverse transcriptase inhibitor EDURANT tablets versus efavirenz (EFV) in antiretroviral treatment-naive, HIV-1-infected adults.

20 Jul 2011

Study finds high C-section rates in Florida, New Jersey and Texas

A report released today by HealthGrades, the nation's most trusted, independent source of physician information and hospital quality outcomes, found that between 2002 and 2009 the C-section, or Cesarean section, rate in the U.S. rose from 27% of all single births to 34%, an all-time high. The highest rates of C-section were found in Florida, New Jersey and Texas, the lowest in Utah, Wisconsin and Colorado.

19 Jul 2011

Thalidomide analog shows promise against sickle cell disease

A thalidomide analog is shaping up as a safe, worthy opponent of sickle cell disease, Georgia Health Sciences University researchers report.

19 Jul 2011

Peak of Australian flu season is imminent so take the necessary precautions now: Experts

The Influenza Specialist Group (ISG) is today warning that high rates of influenza outbreaks have been confirmed in QLD, SA and NSW, but there is still time for most Australians, especially those in at-risk groups, to protect themselves and those around them.

18 Jul 2011

Personal health data in Google Health profile can easily be transferred to Microsoft HealthVault account

Microsoft Corp. today announced that people using the Google Health service, scheduled to be discontinued Jan. 1, 2012, can easily transfer their personal health information stored in a Google Health profile to a Microsoft HealthVault account using the Direct Project messaging protocols established by the Office of the National Coordinator for Health IT.

18 Jul 2011

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.

18 Jul 2011

Pregnancy News and Research

Latest Pregnancy News and Research

FDA approves Merz Aesthetics' XEOMIN for temporary improvement of glabellar lines

Viewpoints: Will Gang of Six compromise work?; endorsing birth control recommendations; Minn. budget deal

Scientists find distinct links between smoking during pregnancy and long-term harm for the child

Senate Commission compiles new threshold limit values for dusts

Women in embattled regions have limited access and means to use contraceptives

Essential criteria for clinical diagnosis of restless legs syndrome

Caffeine reduces women's chances of becoming pregnant

IOM panel recommends insurance coverage for contraception

Roche, Merck sign new non-exclusive agreement for HCV triple combination therapy

Babies of stressed pregnant mums may have lasting effects

Male infertility cause found in defective gene

Australia sees early rise in flu cases

VIVUS to present topiramate exposure, birth defect data at IEC

'Be a Hero for Babies Day' raises $2.75 million for March of Dimes

Janssen presents EDURANT 96-week Phase 3 trial data at International AIDS Society Conference

Study finds high C-section rates in Florida, New Jersey and Texas

Thalidomide analog shows promise against sickle cell disease

Peak of Australian flu season is imminent so take the necessary precautions now: Experts

Personal health data in Google Health profile can easily be transferred to Microsoft HealthVault account

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Pregnancy News and Research

Latest Pregnancy News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in